Calendar PharmaEssentia Corporation LUXEMBOURG S.E.
Stocks
261280558
US7169721047
Biotechnology & Medical Research
|
End-of-day quote
LUXEMBOURG S.E.
2026-08-14
|
5-day change | 1st Jan Change | ||
| 47.00 USD | +4.44% |
|
+22.40% | +247.80% |
| 08-13 | PharmaEssentia Clarifies Report Projecting 2026 Revenue | MT |
| 08-12 | PharmaEssentia Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Chart calendar PharmaEssentia Corporation
Upcoming events on PharmaEssentia Corporation
No events available
Past events on PharmaEssentia Corporation
| 2026-08-10 | Earnings release - Q2 2026 | |
| 2026-08-09 | Board of Directors Meeting | |
| 2026-05-27 | Annual General Meeting | 22:00 |
Past dividends on PharmaEssentia Corporation
| 2026-07-09 | Significant Split/Dividend | 00:00 |
| 2026-07-09 | Ex-dividend date - 1.49015 TWD | 00:00 |
| 2025-09-11 | Significant Split/Dividend | 00:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 5 106 5 589 -8.65% | 9 735 9 552 1.91% | 15 635 15 474 1.04% | 27 759 | 37 077 | 35 594 |
|
EBITDA Million TWD | Released Forecast Spread | -1 645 -1 577 -4.26% | 2 104 1 751 20.12% | 5 327 5 135 3.73% | 13 602 | 16 574 | 16 591 |
|
EBIT Million TWD | Released Forecast Spread | -1 913 -1 373 -39.33% | 1 736 1 773 -2.07% | 4 928 4 868 1.24% | 12 360 | 17 114 | 16 243 |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | -987 -1 446 31.75% | 2 995 3 524 -15.02% | 4 983 4 681 6.44% | 12 675 | 20 091 | 0,00 |
|
Net income Million TWD | Released Forecast Spread | -624 -1 418 56.01% | 2 966 2 801 5.87% | 5 045 5 041 0.09% | 10 490 | 16 251 | 18 540 |
|
EPS TWD | Released Forecast Spread | -1,57 -3,83 59.11% | 7,21 6,83 5.65% | 12,3 12,3 -0.28% | 24,8 | 38,8 | 43,8 |
| Announcement Date | 27/02/24 | 26/02/25 | 03/03/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 3 062 3 102 -1.3% | 3 257 3 251 0.19% | 3 602 3 803 -5.27% | 3 894 4 055 -3.96% | 4 881 4 874 0.15% | 5 121 5 531 -7.41% | 6 855 6 739 1.72% | 7 444 | 8 339 | 8 403 | 9 461 | 11 119 | 11 879 |
|
EBITDA Million TWD | Released Forecast Spread | 636 1 003 -36.57% | 1 666 1 686 -1.16% | 2 204 1 867 18.06% | 3 279 3 018 8.63% | 3 377 | 3 576 | 3 823 | 4 650 | 5 662 | 6 270 | |||
|
EBIT Million TWD | Released Forecast Spread | 541 1 054 -48.61% | 1 105 1 030 7.31% | 1 096 1 399 -21.69% | 1 166 1 362 -14.37% | 1 561 1 542 1.28% | 2 087 1 829 14.09% | 3 155 3 015 4.67% | 3 317 | 3 754 | 3 742 | 4 506 | 5 889 | 6 372 |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | 852 1 382 -38.35% | 1 460 1 240 17.78% | 95,8 1 609 -94.04% | 1 414 1 640 -13.76% | 2 013 1 701 18.33% | 2 336 1 927 21.22% | 3 199 3 114 2.72% | 3 353 | 4 179 | 3 902 | 4 674 | 6 064 | 6 552 |
|
Net income Million TWD | Released Forecast Spread | 1 236 996 24.12% | 1 264 992 27.37% | 832 1 287 -35.33% | 1 473 1 594 -7.59% | 1 476 1 504 -1.84% | 2 150 1 593 34.92% | 2 530 2 603 -2.81% | 2 661 | 3 465 | 3 107 | 3 722 | 4 829 | 5 218 |
|
EPS TWD | Released Forecast Spread | 3,01 2,61 15.09% | 3,09 2,44 26.67% | 2,02 3,16 -35.99% | 3,60 3,89 -7.42% | 3,58 3,58 -0.08% | 5,21 3,83 36.16% | 6,13 6,23 -1.66% | 6,27 | 7,49 | 7,48 | 8,95 | 11,6 | 12,6 |
| Announcement Date | 26/02/25 | 11/05/25 | 13/08/25 | 04/11/25 | 03/03/26 | 14/05/26 | 12/08/26 | - | - | - | - | - | - |
| 2026-08-16 | Board of Directors Meeting | ||
| 2026-08-16 | Earnings release - Q2 2026 | ||
| 2026-08-16 | Board of Directors Meeting | ||
| 2026-08-17 | Earnings release - Q2 2026 | ||
| 2026-08-17 | Earnings presentation | 08:00 | |
| 2026-08-17 | Board of Directors Meeting | ||
| 2026-08-18 | Board of Directors Meeting | ||
| 2026-08-18 | Board of Directors Meeting | ||
| 2026-08-18 | Earnings release - Q2 2026 | ||
| 2026-08-18 | Board of Directors Meeting |
Past sector events for PharmaEssentia Corporation
| 2026-08-13 | Earnings presentation | 16:30 | |
| 2026-08-13 | Earnings release - Q2 2026 | ||
| 2026-08-13 | Earnings presentation | 16:30 | |
| 2026-08-13 | Earnings release - Q2 2026 | ||
| 2026-08-13 | Earnings release - Q2 2026 | ||
| 2026-08-13 | Earnings presentation | 08:00 | |
| 2026-08-13 | Earnings release - Q2 2026 | ||
| 2026-08-13 | Earnings presentation | 17:00 | |
| 2026-08-13 | Earnings release - Q2 2026 | ||
| 2026-08-13 | Earnings presentation | 09:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 6446 Stock
- 261280558 Stock
- Calendar PharmaEssentia Corporation
Select your edition
All financial news and data tailored to specific country editions
















